Antimicrobial Resistance & Stewardship

Since 2019, bioMérieux has partnered with the Fleming Fund to provide high medical value diagnostic solutions, innovative data analytics tools and antimicrobial susceptibility testing in 15 countries located in the Africa and Asia Pacific regions.

While the majority of major drug companies have been scaling back or cutting antibiotic research, diagnostics and advanced data analytics can help preserve existing treatments for patients.

Further investment in and use of technologies such as reporting software can mean that antimicrobial stewardship staff no longer spend weeks working from spreadsheets and can deliver the all-important antibiograms sooner.

With optimized sepsis management protocols and guidance from antimicrobial stewardship programs, it is possible to combat antimicrobial resistance alongside sepsis.

Dr. Esmita Charani speaks about her research on global narratives for antimicrobial stewardship and the importance of resource equity in the fight against AMR.